| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459385 | Radiotherapy and Oncology | 2017 | 6 Pages |
Abstract
QoL and cognitive long-term assessments are feasible also in some patients with GB after a symptomatic progression. Our study demonstrates maintenance of QoL and cognitive summary scales before tumor progression. Moreover, it highlights subgroups according to tumor location and socioeconomic factors.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
B. Flechl, C. Sax, M. Ackerl, R. Crevenna, A. Woehrer, J. Hainfellner, M. Preusser, G. Widhalm, B. Kiesel, C. Lütgendorf-Caucig, K. Dieckmann, C. Steffal, C. Marosi, M.R. Hassler,